Physician profile
Saba Hamiduzzaman
NPI 1700011004
$2,008.68
in general payments reported to CMS, 2019-2025
9 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.27 · 2023: $1,732 · 2024: $142 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,343 · Food and Beverage: $591 · Education: $57.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,343.05 |
| Food and Beverage | $590.88 |
| Education | $57.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,398.05 | 2023 | Single Use Suction Valve (Sterile) |
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.45 | 2023-2024 | Ofev |
| Glaxosmithkline, LLC. | $180.67 | 2023-2025 | Nucala, Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $57.48 | 2023 | |
| Inspire Medical Systems, INC. | $49.41 | 2024 | Inspire |
| Intuitive Surgical, INC. | $46.61 | 2023 | Da Vinci Surgical System |
| Lilly USA, LLC | $25.74 | 2023 | Olumiant, Taltz |
| Breathe Technologies, INC. | $17.27 | 2019 | |
| Genzyme Corporation | $15.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saba Hamiduzzaman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.